Jamieson is pleased to announce that it has advised the management team of Medivet on the sale of the business to CVC Capital Partners VIII.
With over 350 branches in the UK, Medivet is a leading provider of veterinary care, delivering a full spectrum of small animal health services including routine check-ups, 24/7 emergency care, lab & diagnostics and advanced surgery to companion pets across the country. Medivet has a clinical excellence led ethos and unique partnership model delivering a gold-standard of clinical care to patients, whenever and wherever they need it. From its UK foundations, the company has recently expanded with operations in Germany and Spain, with ~50 sites in Europe in partnership with local founders.
Commenting on the announcement, Deirdre Burns, CEO of Medivet said: “I am delighted that CVC has decided for its fund to invest in Medivet to fuel and support our ambitions and growth plans for the UK and Europe, and look forward to working together to bring them to fruition. Over the last 34 years, our Central Partners, Branch Partners and all our people have worked hard to build an outstanding business, centred on delivering exceptional care and service to our patients and clients. In the last few years, the management team have built upon these foundations, transforming the professionalism of our functions and operation, and we are primed to continue our expansion – both in market presence and in the depth of our clinical care, service and expertise.”
The transaction is expected to close in Q4 2021 subject to regulatory approvals.
Tom Burton, Stephen Maxwell and Henry Balcerak advised Deirdre Burns (CEO), Neil Harrington (CFO) and the full Medivet management team on their reinvestment into the new structure and the terms of the new incentive arrangements.
